Reloadable hydrogel system comprising an anti-PEG antibody for treating myocardial infarction
US11135164B2 · kind B2 · utility
0Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 12, 2018 |
| Grant date | Oct 5, 2021 |
| Priority date | — |
| Expiry date | Jan 12, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/65
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A drug delivery system and methods of using such for delivering a peglyated therapeutic agent to heart. The drug delivery system may comprise an antibody embedded in a hydrogel, comprising one or more biodegradable polymers, up to about 60% of which contain inter-chain or intra-chain covalent crosslinks.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.